Risk of Cardiovascular Diseases in Diabetes Mellitus and Serum Concentration of Asymmetrical Dimethylarginine
Introduction. Asymmetric dimethylarginine (ADMA) is a nonselective nitric oxide (NO) synthase inhibitor associated with cardiovascular and metabolic disorders. ADMA plays an important role in the regulation of vascular tone by acting as an endogenous inhibitor of NO synthesis. Objectives. This study...
Saved in:
Main Authors: | Seema L. Jawalekar, Aarti Karnik, Anil Bhutey |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Biochemistry Research International |
Online Access: | http://dx.doi.org/10.1155/2013/189430 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Relation of Asymmetric Dimethylarginine Levels to Macrovascular Disease and Inflammation Markers in Type 2 Diabetic Patients
by: Mustafa Celik, et al.
Published: (2014-01-01) -
Serum Asymmetric Dimethylarginine, Nitrate, Vitamin B12, and Homocysteine Levels in Individuals with Pulmonary Embolism
by: Murat Altuntaş, et al.
Published: (2011-01-01) -
Comparison of Three Sample Preparation Procedures for the Quantification of L-Arginine, Asymmetric Dimethylarginine, and Symmetric Dimethylarginine in Human Plasma Using HPLC-FLD
by: Anne Marie Voigt Schou-Pedersen, et al.
Published: (2018-01-01) -
Omega-3 Status and the Relationship between Plasma Asymmetric Dimethylarginine and Risk of Myocardial Infarction in Patients with Suspected Coronary Artery Disease
by: Heidi Borgeraas, et al.
Published: (2012-01-01) -
Clinical Value of Asymmetrical Dimethylarginine Detection in Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
by: Juan Liu, et al.
Published: (2019-01-01)